Sean McGowan

Stock Analyst at Roth Capital

(1.14)
# 1981
Out of 5,370 analysts
60
Total ratings
44.44%
Success rate
9.67%
Average return
17 Stocks
Name Action PT Current % Upside Ratings Updated
NAGE Niagen Bioscience
Maintains: Strong Buy
10 23
14.11 63% 1 Jun 6, 2025
MNST Monster Beverage
Maintains: Neutral
50 56
63.86 -12.31% 7 May 14, 2025
GRPN Groupon
Maintains: Strong Buy
21 24
35.41 -32.22% 7 Apr 29, 2025
CELH Celsius Holdings
Reiterates: Buy
38 38
43.37 -12.38% 14 Feb 21, 2025
SNYR Synergy CHC
Initiates Coverage On: Buy
10
2.29 336.68% 1 Jan 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 60
29.66 102.29% 7 Dec 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 8
n/a n/a 4 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1 1
2.34 -57.26% 3 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
13.29 50.49% 1 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 5
0.82 509.76% 4 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
25 26
n/a n/a 3 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 4
n/a n/a 2 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
1.95 130.77% 1 Feb 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3
0.83 261.45% 2 Sep 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3
n/a n/a 1 Aug 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 7
n/a n/a 1 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
n/a n/a 1 Oct 1, 2021